| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/25/2008 | US20080318875 Core 2 Glcnac-T Inhibitors |
| 12/25/2008 | US20080318874 Novel Cyclohexane Derivative, Prodrug Thereof and Salt Thereof, and Therapeutic Agent Containing the Same for Diabetes |
| 12/25/2008 | US20080318873 Camptothecin derivatives as chemoradiosensitizing agents |
| 12/25/2008 | US20080318870 Synthetic bile acid compositions and methods |
| 12/25/2008 | US20080318866 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome |
| 12/25/2008 | US20080318847 Use of Antagonist of Oxytocin and/or Vasopressin in Assisted Reproduction |
| 12/25/2008 | US20080318846 Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 12/25/2008 | US20080318843 Device and Method for the Delivery of Drugs for the Treatment of Posterior Segment Disease |
| 12/25/2008 | US20080318839 Ligand activated transcriptional regulator proteins |
| 12/25/2008 | US20080318835 Novel Integrin Ligand ITGL-TSP |
| 12/25/2008 | US20080318788 Microcapsule |
| 12/25/2008 | US20080318338 Drug screening using a high affinity form of Heat Shock Protein-90 (HSP90) that has a 17-allylamino-geldanamycin (17-AAG) binding affinity |
| 12/25/2008 | US20080318320 Targeting vector to the urokinase plasminogen activator receptor |
| 12/25/2008 | US20080318293 Sulfotransferase Inhibitors |
| 12/25/2008 | US20080318253 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy |
| 12/25/2008 | US20080318227 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 12/25/2008 | US20080317938 Dietary Fiber Delivery System |
| 12/25/2008 | US20080317889 dissolving emulsion/emollient in alcohol; clarity; free of acetone and other harsh, dermatologically undesirable solvents; acne vulgaris, rosacea |
| 12/25/2008 | US20080317888 lignan extract comprising a lignan complex including secoisolariciresinol diglucoside;wherein the lignan extract is substantially free of cyanogenic glycosides as determined by measuring free cyanides; use in treating cancer, diabetes, hypertension, lupus, and atherosclerosis |
| 12/25/2008 | US20080317886 Compositions for Preventing and Reducing Delayed Onset Muscle Soreness |
| 12/25/2008 | US20080317885 Compositions and Methods for Treating and Preventing Inflammatory and/or Degenerative Processes in Humans and Other Animals |
| 12/25/2008 | US20080317884 Enhancing Disease Resistance In An Animal |
| 12/25/2008 | US20080317883 Methods for treating depression |
| 12/25/2008 | US20080317876 Use of a magnesium isotope for treating hypoxia and a medicament comprising the same |
| 12/25/2008 | US20080317870 Compositions and Mehtods for Treating and Preventing Cancer Using Analogs of Vitamin D |
| 12/25/2008 | US20080317867 Cosmetic System, and Method for Disguising Skin Defects |
| 12/25/2008 | US20080317862 Organic Compounds Comprising a Glycopyrrolium Salt |
| 12/25/2008 | US20080317859 Stabilization of Testosterone Within Transdermal Devices |
| 12/25/2008 | US20080317858 Formulations of n-(2-acetyl-4,6-dimethylphenyl)-3--2-thiophenecarboxamide |
| 12/25/2008 | US20080317857 V-Atpase Inhibitors of Use in the Treatment of Septic Shock |
| 12/25/2008 | US20080317856 Compositions Containing A Capillary -Active System With Application -Relevant Differentiability, And The Use Thereof |
| 12/25/2008 | US20080317854 Process for the production of an abuse-proofed solid dosage form |
| 12/25/2008 | US20080317853 Mouth Dissolving Pharmaceutical Composition and Process for Preparing the Same |
| 12/25/2008 | US20080317852 Pharmaceutical Combination |
| 12/25/2008 | US20080317851 Immediate release dosage forms containing solid drug disbursions |
| 12/25/2008 | US20080317850 Buccal Delivery System |
| 12/25/2008 | US20080317849 Method for Improving the Medical Treatment of Pain |
| 12/25/2008 | US20080317848 Side effect reduction; retarder coating; embedded in matrix; sustained release |
| 12/25/2008 | US20080317847 Hydrostatic delivery system for controlled delivery of agent |
| 12/25/2008 | US20080317846 Pulsatile release histamine H2 antagonist dosage form |
| 12/25/2008 | US20080317845 Duloxetine Formulation |
| 12/25/2008 | US20080317844 Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Compositions Comprising Same |
| 12/25/2008 | US20080317843 Nanoparticulate formulations of modafinil |
| 12/25/2008 | US20080317841 Pharmaceutical Composition Containing Coated, Floating Particles |
| 12/25/2008 | US20080317840 Compositions and methods for polymer-caged liposomes |
| 12/25/2008 | US20080317839 Amino acid lipids and uses thereof |
| 12/25/2008 | US20080317835 Personalized Nutrient Deficiency Assay Methods |
| 12/25/2008 | US20080317834 Compounds and methods for modulating cerebral amyloid angiopathy |
| 12/25/2008 | US20080317833 Novel Anti-Inflammatory Androstane Derivatives |
| 12/25/2008 | US20080317832 Transdermal delivery system comprising glycopyrrolate to treat sialorrhea |
| 12/25/2008 | US20080317828 Fentanyl compound-containing edible patch to be applied to oral mucosa |
| 12/25/2008 | US20080317822 Methods for Delivery of Nanosome Encapsulated Agents |
| 12/25/2008 | US20080317821 Lipase Inhibitors |
| 12/25/2008 | US20080317819 Iop lowering drug combination or non-combination loaded contact lens with zonal drug delivery areas |
| 12/25/2008 | US20080317815 Induction of a physiological dispersion response in bacterial cells in a biofilm |
| 12/25/2008 | US20080317813 Nanobead releasing medical devices |
| 12/25/2008 | US20080317811 Treatment of Cancer Using Tlr3 Agonists |
| 12/25/2008 | US20080317809 Use of K -252a and Kinase Inhibitors for the Prevention or Treatment of Hmgb1-Associated Pathologies |
| 12/25/2008 | US20080317806 Antiparasitic Compounds |
| 12/25/2008 | US20080317805 Locally administrated low doses of corticosteroids |
| 12/25/2008 | US20080317792 Composition Based on Mineral Concentrates Derived From Precious Stones |
| 12/25/2008 | US20080317774 Composition For Inhibiting Thrombosis |
| 12/25/2008 | US20080317772 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 12/25/2008 | US20080317759 Therapeutic uses of factors which inhibit or neutralize MIF activity |
| 12/25/2008 | US20080317756 Antibodies to Chemokine Alpha-5 |
| 12/25/2008 | US20080317755 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/25/2008 | US20080317754 Human Osteoclast Derived Cathepsin |
| 12/25/2008 | US20080317752 Inhibition of Tumorigenesis by Inhibition of a6b4 Integrin |
| 12/25/2008 | US20080317751 Idiotype Vaccination with Bispecific and Multispecific Immunoglobulin Molecules |
| 12/25/2008 | US20080317749 Use of Cytokine Expression to Predict Skin Inflammation; Methods of Treatment |
| 12/25/2008 | US20080317748 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis |
| 12/25/2008 | US20080317746 Anti-Il2 Antibodies |
| 12/25/2008 | US20080317744 Indole and Benzimidazole Derivatives |
| 12/25/2008 | US20080317739 Method for Treating Skeletal Disorders Resulting from Fgfr Malfunction |
| 12/25/2008 | US20080317737 Drug combination for the treatment of skin disorders |
| 12/25/2008 | US20080317735 Pharmaceutical preparation with RNA as hemostasis cofactor |
| 12/25/2008 | US20080317733 Cosmeceutical Compositions and Methods with Biologically Active Ingredients |
| 12/25/2008 | US20080317731 Phospholipases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 12/25/2008 | US20080317729 Ammonium Salts and Ammonium Salt/Mineral Salt Clathrate Compounds for Use as Vehicle and Effective Form for Pharmaco-Medical Applications and for Use as Phase Transfer Agents for Chemical Applications |
| 12/25/2008 | US20080317727 Method of skin treatment for rosacea using epidermal growth factor |
| 12/25/2008 | US20080317725 Compositions and methods of treating chronic kidney disease |
| 12/25/2008 | US20080317717 Anti-hepatitis b virus ribozymal nucleic acid |
| 12/25/2008 | US20080317710 Methods For Treating Autoimmune or Demyelinating Diseases |
| 12/25/2008 | US20080317709 Methods for treating head or neck cancer using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione |
| 12/25/2008 | US20080317708 Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3dione |
| 12/25/2008 | US20080317704 Control of ice-crystal growth by non-proteinaceous substance |
| 12/25/2008 | US20080317703 Novel Composition for Xerostomia |
| 12/25/2008 | US20080317701 Phosphate Ion Adsorbent |
| 12/25/2008 | US20080317699 Chemically modified dendrimers |
| 12/25/2008 | US20080317698 Personal Care Compositions Containing At Least Two Cationic Polymers and an Anionic Surfactant |
| 12/25/2008 | US20080317692 Suicide substrates of tyrosinase and use thereof |
| 12/25/2008 | US20080317690 Dermatological or oral disease; drug delivery; sustained release; onychomycosis; contains benzoin, a topical active agent and a volatile solvent like ethanol |
| 12/25/2008 | US20080317689 Transdermal Preparation for External Use Containing Antiinflammatory/Analgesic Agent |
| 12/25/2008 | US20080317677 Laser Marked Dosage Forms |
| 12/25/2008 | US20080317673 Method for diagnosing and treating bronchial asthma |
| 12/25/2008 | US20080317671 Non-imidazole heterocyclic compounds |
| 12/25/2008 | US20080317669 Cloning of honey bee allergen C |
| 12/25/2008 | US20080317667 Compositions and methods for inhibiting growth of smad4-deficient cancers |
| 12/24/2008 | WO2008157847A1 Skin and surface disinfectant compositions containing botanicals |
| 12/24/2008 | WO2008157844A1 Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase |